Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Cancer Cachexia 2Neoplasms 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Low-Level Light Therapy 5Radiation 4Radiotherapy 3Propolis 3Morphine 3Methotrexate 3Leucovorin 3Cryotherapy 3Cisplatin 3glucarpidase 2Probiotics 2Pentoxifylline 2Mouthwashes 2Melphalan 2Ketamine 2Interleukin 1 Receptor Antagonist Protein 2Honey 2Glutamine 2Gabapentin 2Fluorouracil 2Fibroblast Growth Factor 7 2Drug Therapy 2Amifostine 2peppermint oil 1pegfilgrastim 1pegaspargase 1oxycodone-acetaminophen 1nelarabine 1maltodextrin 1kang-lai-te 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mucositis × kang-lai-te × Clear all
NCT03101514 2021-06-23

Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study

First Affiliated Hospital of Harbin Medical University

Phase 2 Completed
53 enrolled 11 charts
Head & NeckOther

Head and Neck Neoplasms, Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡